Janet Dunn

7PUBLICATIONS
81CO-AUTHORS
Phylogeny and comparative analysisMedical bacteriologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 12, 2026
Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT.

|Jul 14, 2025
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study.

David Rj Snead, Ayesha S Azam, Jenny Thirlwall

|Mar 07, 2024
Mammographic surveillance after breast cancer.

Andy Evans, Janet Dunn, Peter Kevin Donnelly

|Jul 14, 2023
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.

Stella Bowcock, Catherine Atkin, Gulnaz Iqbal

|Oct 20, 2020
Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.

Michael Kosmin, Anwar R Padhani, Andrew Gogbashian

|Sep 04, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.

Helena Earl, Louise Hiller, Anne-Laure Vallier

Pageof 2

Frequent Collaborators

4 joint publications

Helen Higgins

3 joint publications

Claire T Hulme

2 joint publications

Mark T Drayson

2 joint publications

Sophie Gasson